โ† Back to blog
HEALTH

Stopping Ozempic or Wegovy: Will the Weight Come Back?

Viivaa
ยท 6 min read
Woman with a larger body working out on an elliptical trainer while a smiling coach cheers her on
Photo: Andres Ayrton / Pexels

GLP-1 medications such as semaglutide (sold as Ozempic and Wegovy) and tirzepatide have changed the conversation about weight. Plenty of people are now asking the next question: what happens if I stop?

Maybe the cost is hard to keep up with, side effects are getting in the way, or you simply don't want to be on a medication long term. Whatever your reason, it's a fair question, and it deserves a calm, honest answer rather than scare stories or miracle claims.

Here's what the research currently shows, what it doesn't show yet, and why the conversation with your doctor matters most.

First, a quick refresher on energy balance

Body weight responds to the balance between the energy we take in and the energy we use. But it doesn't respond instantly. Modelling work from the US National Institutes of Health found that body weight adjusts to a change in energy intake slowly, with a "half time" of about a year [1]. In other words, weight drifts toward a new level gradually rather than jumping overnight.

That matters here because GLP-1 medications work largely on the intake side. A review of lifestyle treatment alongside newer anti-obesity medications describes how drugs like semaglutide and tirzepatide reduce energy intake by strongly increasing feelings of fullness and reducing hunger [2]. When a medication that turns down appetite is stopped, it's reasonable to expect that appetite can change too, and that weight may shift over the following months.

How common is stopping?

Very common, it turns out, and you're not doing anything unusual by thinking about it.

A large US study using electronic health records followed 125,474 adults with overweight or obesity who started liraglutide, semaglutide or tirzepatide between 2018 and 2023 [3]. Within one year [3]:

  • 64.8% of people without type 2 diabetes had stopped
  • 46.5% of people with type 2 diabetes had stopped

People who lost more weight were less likely to stop, while moderate or severe gastrointestinal side effects were linked with a higher chance of stopping [3]. Among people with type 2 diabetes, higher income was also linked with lower rates of stopping [3].

Many people also went back on. Among those who stopped and had a weight recorded at that time, about 36% of people without type 2 diabetes and 47% of those with it restarted within a year [3]. Regaining weight after stopping was associated with a higher likelihood of restarting [3]. The authors noted that differences in access and adherence could widen existing health gaps [3].

Interest in these medications is broad. In the United States, a nationally representative KFF poll from spring 2024 found that about one in eight US adults (12%) had ever taken a GLP-1 drug, including 6% who were currently taking one [4]. About half of those who had taken one (54%) said the cost was difficult to afford [4].

What happens to weight after stopping?

Timeline diagram of the period during and after stopping medication

Two recent sources look at this question in different ways, and it helps to read them side by side.

A 2026 systematic review and meta-analysis in The BMJ pooled 37 studies with 9,341 participants who had taken a weight management medication for at least eight weeks and were followed after stopping [5]. It included several types of medication, not only GLP-1s. On average [5]:

  • Weight came back at about 0.4 kg (about 0.9 lb) per month after stopping
  • Based on those trends, weight was projected to return to the starting point about 1.7 years after stopping
  • For the newer, more effective drugs (semaglutide and tirzepatide), regain was faster, at about 0.8 kg (1.8 lb) per month, with a projected return to baseline at about 1.5 years
  • Improvements in markers such as blood pressure, cholesterol and blood sugar were projected to return to baseline within about 1.4 years
  • Regain was faster after stopping medication than after ending a behavioural weight management programme

The authors suggested caution about short-term use of these medications without a broader approach to weight management [5]. Keep in mind that these are averages and projections across many studies, not predictions for any one person.

A real-world analysis from Epic Research (2025) looked at health records for 188,722 people who had taken semaglutide, liraglutide or tirzepatide for at least 90 days and lost at least 5 pounds (about 2.3 kg) before stopping [6]. Among those with weight readings two years later [6]:

  • About 56% (semaglutide), 52% (liraglutide) and 55% (tirzepatide) had kept their weight off or lost more
  • Full regain occurred in about 23%, 27% and 21%, respectively
  • The mix of outcomes was fairly stable after the first year

This is a research brief rather than a peer-reviewed paper. It only included people with follow-up weight readings, and people who restarted a GLP-1 or began another weight loss medication were no longer counted from that point [6]. The authors also note that people with more frequent weigh-ins might represent the extremes of weight change [6].

So which is right? The two sources answer slightly different questions with different methods and groups of people. Taken together, a fair summary is: on average, weight tends to come back after stopping, but individual experiences vary widely. Neither source can tell you what will happen to you.

Where habits come in

The review on lifestyle and anti-obesity medications points out that little is known about whether people who lose weight with these drugs go on to adopt the eating and activity patterns that support body composition, heart and metabolic health, and quality of life [2]. The authors suggest that, alongside these medications, lifestyle support may shift from simply cutting calories toward building those healthier patterns [2].

That's a useful way to think about it, whether you're on a medication, coming off one, or never took one: the habits you build are yours to keep.

Practical takeaways

  1. Talk to your doctor before stopping. Don't stop or change a prescribed medication on your own. Your doctor can help you plan the timing, dose changes and follow-up that suit your health.
  2. Bring your reasons to the conversation. Cost, side effects or personal preference are all valid. There may be options you haven't considered.
  3. Plan for appetite changes. Knowing that hunger may feel different can help you prepare with regular meals and satisfying foods.
  4. Keep an eye on trends, not single days. Gentle, regular check-ins can help you and your doctor notice changes early.
  5. Build habits now. Eating patterns, movement and sleep routines you build during treatment can stay with you afterwards.
  6. Be kind to yourself. Weight change after stopping a medication is a common biological response, not a personal failure.

Building habits that last

Whatever your treatment path looks like, everyday habits are the part you carry with you. Viivaa helps you build these healthy habits one small step at a time, so they feel doable and sustainable.

Discover Viivaa โ†’

This article is for general information only and isn't medical advice. It doesn't recommend starting, continuing or stopping any medication. Please talk to your doctor or another qualified health professional before making any change to a prescribed treatment.

References

  1. Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet. 2011;378(9793):826โ€“837. https://doi.org/10.1016/S0140-6736(11)60812-X
  2. Wadden TA, Chao AM, Moore M, et al. The role of lifestyle modification with second-generation anti-obesity medications: comparisons, questions, and clinical opportunities. Curr Obes Rep. 2023;12(4):453โ€“473. https://doi.org/10.1007/s13679-023-00534-z
  3. Rodriguez PJ, Zhang V, Gratzl S, et al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw Open. 2025;8(1):e2457349. https://doi.org/10.1001/jamanetworkopen.2024.57349
  4. Montero A, Sparks G, Presiado M, Hamel L. KFF Health Tracking Poll May 2024: The Public's Use and Views of GLP-1 Drugs. KFF; May 10, 2024. https://www.kff.org/health-costs/poll-finding/kff-health-tracking-poll-may-2024-the-publics-use-and-views-of-glp-1-drugs/
  5. West S, Scragg J, Aveyard P, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ. 2026;392:e085304. https://doi.org/10.1136/bmj-2025-085304
  6. Bartelt K, Deckert J, Franklin B, Barkley E. Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss. Epic Research; September 9, 2025. https://www.epicresearch.org/articles/two-years-after-stopping-glp-1s-most-patients-sustain-at-least-some-weight-loss/